1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Hanshang Group Co., Ltd.

Hanshang Group Co., Ltd.

600774.SS
Hanshang Group Co., Ltd.CN flagShanghai Stock Exchange
6.55
CNY
-0.17
- -
1.93BMarket Cap
Hanshang Group Co., Ltd.
600774.SS
(Shanghai Stock Exchange)

Recent

price

6.55

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
3.43
3.82
4.14
4.62
4.07
4.33
4.18
5.8
4.77
5.1
2.18
5.98
4.7
4.77
4.03
3.48
3.62
Revenue per Share
0.06
0.07
0.1
0.08
0.08
0.04
0.05
0.09
0.09
0.13
0.2
0.35
0.31
0.21
-0.05
-0.59
-0.07
Basic EPS, GAAP
0.42
-0.23
0.2
0.22
0.18
-0.04
0.16
0.11
0.16
0.01
0.12
0.9
0.04
0.38
0.45
0.28
0.01
Free Cash Flow per Basic Share
0.09
0.1
0.11
0.14
0.08
0.08
0.1
0.11
0.13
0.44
0.28
0.38
0.27
0.16
0.12
0.13
0.11
Dividend per Share
1.37
1.37
1.49
1.55
1.53
1.6
1.61
2.15
1.71
1.8
2
2.46
2.25
2.32
2.27
1.64
2.26
Book Value per Share
2.39
2.6
2.71
2.78
2.73
2.81
2.81
3.7
2.95
3.1
1.26
4.95
4.14
4.4
4.32
3.72
4.32
Tangible Book Value per Share
215
226
222
217
231
227
227
175
227
227
227
247
295
291
292
296
294
Basic Weighted Avg Shares
738
865
918
1,003
941
984
949
1,012
1,082
1,157
495
1,475
1,387
1,390
1,175
1,032
1,062
Sales/Revenue/Turnover
2.73
1.47
2.16
2.59
1.94
3.48
2.6
3.46
5.08
4.54
-0.03
9.92
7.62
8.35
3.86
1.65
2.41
Operating Margin (%)
47
48
52
53
57
58
60
66
65
69
76
124
137
143
145
139
- -
Depreciation Expense
13
16
22
17
20
10
12
16
20
30
45
86
90
61
-15
-175
-21
Net Income, GAAP
45.36
11.77
21.46
69.68
19.62
40.84
61.28
21.8
21.11
17.53
7.33
19.27
23.03
28.54
- -
- -
1,232.21
Effective Tax Rate (%)
1.8
1.81
2.42
1.67
2.08
1.03
1.23
1.63
1.81
2.58
9.19
5.81
6.51
4.4
-1.24
-16.95
-2.02
Profit Margin (%)
-685
-651
-684
-749
-637
-692
-682
-682
-767
-476
-944
-502
-596
-746
-799
-762
-797
Working Capital
78
104
94
75
149
119
139
163
50
288
566
184
350
326
224
161
176
LT Debt
576
646
659
659
683
690
687
695
717
749
835
1,793
1,787
1,829
1,804
1,616
1,801
Total Equity
1.05
1.03
1.38
0.7
1.3
1.78
0.81
2.28
3.61
3.48
-0.01
4.89
3.05
3.02
- -
- -
- -
Return on Invested Capital (%)
4.22
5.58
6.29
4.26
4.23
3.27
3.09
3.83
4.24
4.17
7.11
8.22
8.92
5.98
- -
- -
24.87
Return on Capital (%)
4.59
5.18
6.93
5.01
5.66
2.83
3.19
4.44
5.13
7.5
10.54
16.13
14.22
9.15
-2.18
-30.49
-3.19
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
631
611
620
LT Borrowings
137
147
87
LT Finance Leases
87
88
89
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
295
295
295
Market Capitalization
2,207
2,221
2,491

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
630
682
585
Cash, Cash Equivalents & STI
136
169
85
Accounts Receivable, Net
115
126
155
Inventories
258
241
221
Total Current Liabilities
1,429
1,499
1,382
Payables & Accruals
- -
- -
- -
ST Debt
631
611
620
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.49%
21.01%
-10.41%
Free Cash Flow
236.55%
290.76%
-37.76%
Net Income, GAAP
121.58%
207.25%
1,098.54%
Sales/Revenue/Turnover
12.42%
32.9%
-12.23%
Total Cash Common Dividend
25.66%
-3.69%
16.11%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
337
289
278
272
1,175
2025
257
255
268
- -
1,032
2026
228
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
- -
- -
- -
-0.05
2025
0.01
- -
- -
- -
-0.59
2026
-0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
- -
- -
- -
0.12
2025
0.03
- -
- -
- -
0.13
2026
0.05
- -
- -
- -
- -
Similar Companies
Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS)
Medivir AB (publ) (0GP7.L)
Praxsyn Corporation (PXYN)
Welcure Drugs & Pharmaceuticals Limited (WELCURE.BO)
TRxADE HEALTH, Inc. (MEDS)
TMT (India) Ltd. (TMTIND-B1.BO)
Business
Hanshang Group Co., Ltd. (600774.SS) operates as a diversified conglomerate principally engaged in retail, healthcare, and exhibition services in China. The company offers retail through its major shopping centers including Hanshang Ginza Shopping Center, 21st Century Shopping Center, Wuzhan Shopping Center, and Wuhan Wedding Photography Materials City; healthcare products and services encompassing medicines via subsidiaries such as Chengdu Dikang Pharmaceutical, Dikang Zhongke, Chongqing Dikang Traditional Chinese Medicine, Dikang Changjiang, and Hanshang Biotechnology (Chengdu); medical equipment; assisted reproduction and medical care through Wuhan Huake Reproductive Gynecology Hospital and Tongji Technology Group; healthy drinks; and exhibition operations at Wuhan International Expo Center and hosted Wuhan Living venue. It also pursues new businesses in low-altitude airport operations via Hanshang Low-Altitude Airport and grain and oil through Hanshang Grain and Oil. Founded in 1990 and headquartered in Wuhan, Hubei Province, the company, formerly known as Wuhan Hanshang Group Co., Ltd., primarily serves consumer and healthcare markets across China. Recent developments include an agreement to acquire Zhen An Industrial Co., Ltd., along with ongoing efforts to optimize non-core assets as noted in its 2024 annual report.